GLP-3

Product Overview
GLP-3 is a cutting-edge triple receptor agonist peptide engineered to activate GLP‑1, GIP, and glucagon receptors simultaneously. This synergistic approach is under active investigation for its potential to support fat loss, appetite regulation, and metabolic health in research settings.

PLEASE NOTE:

PEPTIDES ARRIVE AS LYOPHILIZED POWDER AND MUST BE RECONSTITUTED WITH BACTERIOSTATIC WATER FOR INJECTION.

Key Research Insights on GLP-3:

• Triple Pathway Fat-Burning Activation
  GLP-3’s unique mechanism stimulates GLP-1R, GIPR, and GCGR, combining appetite suppression with increased energy expenditure for a powerful dual-effect fat reduction profile.
• Increased Resting Metabolism
  Through glucagon receptor (GCGR) activation, GLP-3 mobilizes glycogen and fat stores, raising basal metabolic rate (BMR) and promoting continuous fat oxidation, even during rest and sleep.
• Appetite Control & Gastric Slowing
  By targeting GLP-1 and GIP receptors, GLP-3 delays gastric emptying and enhances feelings of fullness—helping reduce caloric intake without severe gastrointestinal side effects.
• Extended Circulation Time
  Featuring a fatty acid-modified (acylated) backbone, this peptide is designed for prolonged activity in the bloodstream.
• Promising Preclinical & Phase 2 Results
  Studies report body weight reductions of up to ~24% over 48 weeks, along with decreases in waist circumference, triglyceride levels, and improvements in HbA1c markers.
• Metabolic & Cardiovascular Research Potential
  GLP-3 is currently being explored for its impact on insulin sensitivity, lipid profiles, and heart health through its multi-receptor activation.

Disclaimer
For research use only. Not for human consumption or for use in medical, veterinary, or household applications. By purchasing this product, you agree to all applicable Terms & Conditions.